<?xml version="1.0" encoding="UTF-8"?>
<ref id="B117-pharmaceuticals-13-00096">
 <label>117.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Caly</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Druce</surname>
    <given-names>J.D.</given-names>
   </name>
   <name>
    <surname>Catton</surname>
    <given-names>M.G.</given-names>
   </name>
   <name>
    <surname>Jans</surname>
    <given-names>D.A.</given-names>
   </name>
   <name>
    <surname>Wagstaff</surname>
    <given-names>K.M.</given-names>
   </name>
  </person-group>
  <article-title>The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro</article-title>
  <source>Antivir. Res.</source>
  <year>2020</year>
  <volume>178</volume>
  <fpage>104787</fpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2020.104787</pub-id>
  <pub-id pub-id-type="pmid">32251768</pub-id>
 </element-citation>
</ref>
